AI's Rare Disease Wins Obscure a Harder Clinical Reality

DeepRare's performance advantage over experienced physicians — demonstrated in a Nature-published study using rigorous diagnostic testing — makes it one of the more credible AI clinical tools to emerge this year. The system does not guess; it reasons, cross-checks, and revises, which makes its outputs auditable in a way that earlier diagnostic AI was not. That is a real step forward in clinical trust.